| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.28 | 0.1 |